Liver Fibrosis and Cirrhosis

In this track, researchers investigate the pathogenesis, natural history, and complications of liver fibrosis and cirrhosis. Studies explore non-invasive methods for assessing liver fibrosis severity, including transient elastography, magnetic resonance elastography, and serum biomarkers, and evaluate antifibrotic therapies targeting key signaling pathways involved in fibrogenesis, such as the renin-angiotensin-aldosterone system (RAAS) and the transforming growth factor-beta (TGF-β) pathway.

    Liver Fibrosis and Cirrhosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in